- Home
- About
-
- < Injectables
-
- < By Skin Concern
- Acne Scarring
- Active Acne
- Age Management
- Age Spots/Sun Damage
- Brown Spots
- Cheek and Lip Enhancement
- Chin Enhancement
- Eyelid Wrinkles
- Facial Optimization
- Facial Veins/Capillaries
- Facial Volume Loss
- Fine Lines & Wrinkles
- Frown Lines
- Hyperpigmentation/ Uneven Skintone
- Large Pores
- Melasma & Freckles
- Rosacea/Redness
- Scars
- Skin Laxity
- Lip Enhancements
- Unwanted Hair
- Wrinkles
- Sign In
- Sign Up
Latisse® 5ml
Earn 2 points for writing a review for this productAn FDA-approved product to increase eyelash growth, including length, thickness, and darkness.
15% OFF All Skincare Products
*Consultation required. Can’t be combined with any other offer. Add to cart and discount will apply.
Must be a patient with an existing prescription on file to purchase this product.
Click here if you are interested in scheduling a consultation.
$188.00
LATISSE® is the first and only FDA-approved prescription product indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness.
Upon discontinuation of treatment, eyelash growth is expected to return to its pretreatment level. Individual results may vary.
| Benefits |
|
|---|---|
| FAQs | N/A |
| Treatment Problem or Condition | Thin or Inadequate Lashes |
| Size | 5 ml |
| Brand | Latisse |
Write Your Own Review
N/A
Active ingredient: bimatoprost
Inactive ingredients: benzalkonium chloride; sodium chloride; sodium phosphate, dibasic; citric acid; and purified water. Sodium hydroxide and/or hydrochloric acid may be added to adjust pH. The pH during its shelf life ranges from 6.8 - 7.8.
We found other products you might like!
Frequently bought together
@rashidplasticsurgery
FOLLOW US ON INSTAGRAMREQUEST AN APPOINTMENT
*required fields
Sign up for NEWS AND SPECIALS!
Don’t miss out on our updates and promotions! Subscribe to our mailing list to receive updates on our new products, services, specials, events, and much more.
Earn 2 points for subscribing to newsletter
